T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis

por Grahl, S., Bussas, M., Pongratz, V., Kirschke, J. S., Zimmer, C., Berthele, A., Hemmer, B., Mühlau, M.
Publicado 2020

Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing–Remitting Multiple Sclerosis

por Grahl, S., Bussas, M., Wiestler, B., Eichinger, P., Gaser, C., Kirschke, J., Zimmer, C., Berthele, A., Hemmer, B., Mühlau, M.
Publicado 2021